Table 1 Clinical characteristics of COVID-19 patients according to disease severity
From: Clinical characteristics of 134 convalescent patients with COVID-19 in Guizhou, China
Total N = 134 | Severe N = 19 | Non-severe N = 115 | P value | |
|---|---|---|---|---|
Age, median (IQR), y | 33.0 (21.8–46.3) | 53.0 (37.0–61.0) | 30.0 (20.0–42.0) | < 0.001 |
Sex, male n (%) | 69 (51.5%) | 11 (57.9%) | 58 (50.4%) | 0.547 |
Exposure history within past 14 days, n (%) | ||||
Living in Hubei | 41 (30.6%) | 8 (42.1%) | 33 (28.7%) | 0.007 |
Recently visited Hubei | 32 (23.9%) | 4 (21.1%) | 28 (24.3%) | |
Contact with people from Hubei | 27 (20.1%) | 7 (36.8%) | 20 (17.4%) | |
Contact with other confirmed patients | 34 (25.4%) | 0 | 34 (29.6%) | |
Cluster cases, n (%) | 72 (53.7%) | 11 (57.9%) | 61 (53.0%) | 0.694 |
Comorbidities, n (%) | ||||
Any | 25 (18.7%) | 12 (63.2%) | 13 (11.3%) | < 0.001 |
Diabetes | 10 (7.5%) | 6 (31.6%) | 4 (3.5%) | < 0.001 |
Hypertension | 14 (10.4%) | 7 (36.8%) | 7 (6.1%) | < 0.001 |
Coronary heart disease | 1 (0.7%) | 1 (5.3%) | 0 | 0.142 |
Chronic bronchitis | 1 (0.7%) | 1 (5.3%) | 0 | 0.142 |
Gout | 2 (1.5%) | 1 (5.3%) | 1 (0.9%) | 0.264 |
Cancer | 1 (0.7%) | 0 | 1 (0.9%) | > 0.99 |
AIDS | 1 (0.7%) | 0 | 1 (0.9%) | > 0.99 |
Thyroid disease | 2 (1.5%) | 2 (10.5%) | 0 | 0.019 |